PowderJect Pharmaceuticals completes vendor placing of shares and acquisition of SBL Vaccin from Active Biotech for £35.5m, 75 per cent of which came from the placing.

PowderJect advised by CMS Cameron McKenna (John Burton) and Mannheimer Swartling Advokatbyra in Sweden. Financial adviser WestLB Panmure advised by Ashurst Morris Crisp.